V体育安卓版 - Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official VSports app下载. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely V体育官网. .

. 2008 Jan;13(1):48-57.
doi: 10.1016/j.ccr.2007.12.008.

VSports在线直播 - MicroRNA signature predicts survival and relapse in lung cancer

Sung-Liang Yu  1 , Hsuan-Yu Chen, Gee-Chen Chang, Chih-Yi Chen, Huei-Wen Chen, Sher Singh, Chiou-Ling Cheng, Chong-Jen Yu, Yung-Chie Lee, Han-Shiang Chen, Te-Jen Su, Ching-Cheng Chiang, Han-Ni Li, Qi-Sheng Hong, Hsin-Yuan Su, Chun-Chieh Chen, Wan-Jiun Chen, Chun-Chi Liu, Wing-Kai Chan, Wei J Chen, Ker-Chau Li, Jeremy J W Chen, Pan-Chyr Yang
Affiliations
Free article

V体育安卓版 - MicroRNA signature predicts survival and relapse in lung cancer

VSports app下载 - Sung-Liang Yu et al. Cancer Cell. 2008 Jan.
Free article

"V体育安卓版" Abstract

We investigated whether microRNA expression profiles can predict clinical outcome of NSCLC patients. Using real-time RT-PCR, we obtained microRNA expressions in 112 NSCLC patients, which were divided into the training and testing sets. Using Cox regression and risk-score analysis, we identified a five-microRNA signature for the prediction of treatment outcome of NSCLC in the training set. This microRNA signature was validated by the testing set and an independent cohort. Patients with high-risk scores in their microRNA signatures had poor overall and disease-free survivals compared to the low-risk-score patients. This microRNA signature is an independent predictor of the cancer relapse and survival of NSCLC patients. VSports手机版.

PubMed Disclaimer

Publication types

V体育安卓版 - MeSH terms

LinkOut - more resources